Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04424004 · ClinicalTrials.gov registry record
MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 300
- Enrollment target
NCT04424004: Completed study, sponsored by Duke University.
NCT04424004 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04424004 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The objectives of this research is to: * Assess perceptions, concerns, and practices related to the COVID-19 pandemic and mitigation strategies using the MURDOCK Study Community Registry and Biorepository population as a measure of these features in Cabarrus County through a biweekly electronic survey. * Estimate the prevalence and change in prevalence of COVID-19 infection based on responses to questionnaire items on symptoms and practices using a biweekly electronic survey. * Among respondents to the baseline questionnaire, conduct at home mid-turbinate nasal swab collection for viral PCR testing for active COVID-19 infection as an estimate of the prevalence of active infection in Cabarrus County. * Among respondents to the baseline questionnaire, conduct serologic testing for IgG antibodies to SARS-CoV-2 as an estimate of the prevalence of exposure and potential immunity to COVID-19.
Primary Outcome
RedCap link will be sent to participants electronically and they will complete and submit the questionnaire.
Interventions
- OTHER COVID-19 PCR and serology testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-06-09 |
| Est. Completion | 2021-12-02 |
What the finished NCT04424004 record still lists
NCT04424004 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which COVID-19 PCR and serology testing is the first listed.
NCT04424004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04424004 about?
NCT04424004 is a clinical study titled "MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study". The objectives of this research is to: * Assess perceptions, concerns, and practices related to the COVID-19 pandemic and mitigation strategies using the MURDOCK Study Community Registry and Biorepository population as a measure of these features in Cabarrus County through a biweekly electronic sur...
What is the current status of trial NCT04424004?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2020-06-09. Estimated completion is 2021-12-02.
What interventions are being tested in trial NCT04424004?
The interventions under investigation include: COVID-19 PCR and serology testing (OTHER).
Who is sponsoring clinical trial NCT04424004?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI